Treatment of the hypoxia-exposed cells with echinomycin, a transcriptional inhibitor of HIF-1α, significantly reduced hypoxia-induced miR-210 levels, indicating the transcriptional activation of miR-210-3p by HIF-1α in GBM [81]. This evidence concerns the gene HIF1A and glioblastoma.